Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Potent heterocyclic antithrombotic agents discovered by Lilly

Jan. 25, 1999

Integrin receptor antagonists, prodrugs and transdermal iontophoretic administration

Jan. 22, 1999

DuPont presents potent, orally active antiplatelet agent with good duration of action

Jan. 21, 1999

New market introduction for Organon's anticoagulant

Jan. 20, 1999

Oral heparin shown equivalent in efficacy and safety to injectable heparin

Jan. 19, 1999

Z-335 characterized as potent, orally effective and long-acting antiplatelet/antithrombotic agent

Jan. 19, 1999

Beraprost to enter clinical trials in North America

Jan. 18, 1999

FDA approves Pletal for intermittent claudication

Jan. 18, 1999

FDA approves home use of Lovenox in patients with potentially life-threatening blood clots

Jan. 8, 1999

Potent thrombin inhibitors with heterocyclic structure synthesized at Lilly

Jan. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.